Pleomorphic giant cell carcinoma of the prostate

Antonio Lopez-Beltran, John Eble, David C. Bostwick

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

We report the clinical and pathologic features of 2 cases of pleomorphic giant cell carcinoma of the prostate. One case was found at autopsy in a 77-year-old man and was composed of high-grade prostatic adenocarcinoma with prominent anaplastic giant cells. The patient presented with metastases to multiple retroperitoneal lymph nodes, liver, and lumbar vertebrae. The second case occurred in a 45-year-old man who underwent transurethral resection of the prostate and was found to have high-grade prostatic adenocarcinoma with an extensive anaplastic giant cell component. The patient presented with distant metastases and died within 9 months. Both regular adenocarcinoma and anaplastic giant tumor cells displayed cytoplasmic immunoreactivity for prostate-specific antigen, prostatic acid phosphatase, and keratin AE1/AE3; in one case, scattered cells were also positive for chromogranin and epithelial membrane antigen. Pleomorphic giant cell carcinoma is a rare variant of prostatic adenocarcinoma with a poor prognosis that should be considered in the differential diagnosis of prostatic pleomorphic tumors.

Original languageEnglish (US)
Pages (from-to)683-685
Number of pages3
JournalArchives of Pathology and Laboratory Medicine
Volume129
Issue number5
StatePublished - May 2005

Fingerprint

Giant Cell Carcinoma
Prostate
Adenocarcinoma
Giant Cells
Neoplasm Metastasis
Chromogranins
Giant Cell Tumors
Mucin-1
Lumbar Vertebrae
Transurethral Resection of Prostate
Cellular Structures
Prostate-Specific Antigen
Keratins
Autopsy
Differential Diagnosis
Lymph Nodes
Liver
Neoplasms

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

Pleomorphic giant cell carcinoma of the prostate. / Lopez-Beltran, Antonio; Eble, John; Bostwick, David C.

In: Archives of Pathology and Laboratory Medicine, Vol. 129, No. 5, 05.2005, p. 683-685.

Research output: Contribution to journalArticle

Lopez-Beltran, A, Eble, J & Bostwick, DC 2005, 'Pleomorphic giant cell carcinoma of the prostate', Archives of Pathology and Laboratory Medicine, vol. 129, no. 5, pp. 683-685.
Lopez-Beltran, Antonio ; Eble, John ; Bostwick, David C. / Pleomorphic giant cell carcinoma of the prostate. In: Archives of Pathology and Laboratory Medicine. 2005 ; Vol. 129, No. 5. pp. 683-685.
@article{7e6829f9210b4bd6af95382b2e591e96,
title = "Pleomorphic giant cell carcinoma of the prostate",
abstract = "We report the clinical and pathologic features of 2 cases of pleomorphic giant cell carcinoma of the prostate. One case was found at autopsy in a 77-year-old man and was composed of high-grade prostatic adenocarcinoma with prominent anaplastic giant cells. The patient presented with metastases to multiple retroperitoneal lymph nodes, liver, and lumbar vertebrae. The second case occurred in a 45-year-old man who underwent transurethral resection of the prostate and was found to have high-grade prostatic adenocarcinoma with an extensive anaplastic giant cell component. The patient presented with distant metastases and died within 9 months. Both regular adenocarcinoma and anaplastic giant tumor cells displayed cytoplasmic immunoreactivity for prostate-specific antigen, prostatic acid phosphatase, and keratin AE1/AE3; in one case, scattered cells were also positive for chromogranin and epithelial membrane antigen. Pleomorphic giant cell carcinoma is a rare variant of prostatic adenocarcinoma with a poor prognosis that should be considered in the differential diagnosis of prostatic pleomorphic tumors.",
author = "Antonio Lopez-Beltran and John Eble and Bostwick, {David C.}",
year = "2005",
month = "5",
language = "English (US)",
volume = "129",
pages = "683--685",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "5",

}

TY - JOUR

T1 - Pleomorphic giant cell carcinoma of the prostate

AU - Lopez-Beltran, Antonio

AU - Eble, John

AU - Bostwick, David C.

PY - 2005/5

Y1 - 2005/5

N2 - We report the clinical and pathologic features of 2 cases of pleomorphic giant cell carcinoma of the prostate. One case was found at autopsy in a 77-year-old man and was composed of high-grade prostatic adenocarcinoma with prominent anaplastic giant cells. The patient presented with metastases to multiple retroperitoneal lymph nodes, liver, and lumbar vertebrae. The second case occurred in a 45-year-old man who underwent transurethral resection of the prostate and was found to have high-grade prostatic adenocarcinoma with an extensive anaplastic giant cell component. The patient presented with distant metastases and died within 9 months. Both regular adenocarcinoma and anaplastic giant tumor cells displayed cytoplasmic immunoreactivity for prostate-specific antigen, prostatic acid phosphatase, and keratin AE1/AE3; in one case, scattered cells were also positive for chromogranin and epithelial membrane antigen. Pleomorphic giant cell carcinoma is a rare variant of prostatic adenocarcinoma with a poor prognosis that should be considered in the differential diagnosis of prostatic pleomorphic tumors.

AB - We report the clinical and pathologic features of 2 cases of pleomorphic giant cell carcinoma of the prostate. One case was found at autopsy in a 77-year-old man and was composed of high-grade prostatic adenocarcinoma with prominent anaplastic giant cells. The patient presented with metastases to multiple retroperitoneal lymph nodes, liver, and lumbar vertebrae. The second case occurred in a 45-year-old man who underwent transurethral resection of the prostate and was found to have high-grade prostatic adenocarcinoma with an extensive anaplastic giant cell component. The patient presented with distant metastases and died within 9 months. Both regular adenocarcinoma and anaplastic giant tumor cells displayed cytoplasmic immunoreactivity for prostate-specific antigen, prostatic acid phosphatase, and keratin AE1/AE3; in one case, scattered cells were also positive for chromogranin and epithelial membrane antigen. Pleomorphic giant cell carcinoma is a rare variant of prostatic adenocarcinoma with a poor prognosis that should be considered in the differential diagnosis of prostatic pleomorphic tumors.

UR - http://www.scopus.com/inward/record.url?scp=18144418914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18144418914&partnerID=8YFLogxK

M3 - Article

VL - 129

SP - 683

EP - 685

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 5

ER -